National Health Act 1953 Amendment determination under subsections 85AB(1) and 85ac(1) drugs on F1 and drugs in Part A of F2 (No. PB 66 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 66 of 2009

Amendment determination under subsections 85AB(1) and 85AC(1) of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 85AB(1) and 85 AC(1) of the National Health Act 1953.

Dated 6 July 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Determination – drugs on F1 and drugs in Part A of F2     

1.         Commencement

This instrument commences on 1 August 2009.

2.         Amendment of PB 95 of 2007

Schedule 1 amends PB 95 of 2007.

Schedule 1   Amendments

[1]       Paragraph 2, Drugs on F1, after “Amino acid formula

without phenylalanine and vitamins with minerals”,

insert:  “Arsenic trioxide”,

[2]       Paragraph 2, Drugs on F1, after “Fludarabine”,

insert: “High fat formula with vitamins, minerals

and trace elements and low in protein and carbohydrate”,

[3]       Paragraph 2, Drugs on F1, after “Nilotinib”,

insert:“Praziquantel”, “Rivaroxaban”,

[4]       Paragraph 2, Drugs on F1, after “Sitagliptin”,

insert:“Soy lecithin”,

[5]       Paragraph 3, Drugs on F2, after The listed drugs

insert as first entry:  “Azithromycin”,

[6]       Paragraph 3, Drugs on F2, after “Bicalutamide”,

insert: “Bisoprolol”, “Cabergoline”,

[7]       Paragraph 3, Drugs on F2, after “Gemcitabine”,

insert: “Glucose”, “Morphine”,

[8]       Paragraph 3, Drugs on F2

omit the words:

and “Risperidone”

and substitute:

, “Risperidone”, “Sodium chloride” and “Sodium lactate compound”

[9]       Paragraph 4, Drugs in Part A of F2

insert as first entry:  “Azithromycin”,

[10]     Paragraph 4, Drugs in Part A of F2, after “Bicalutamide”,

insert: “Bisoprolol”, “Cabergoline”,

[11]     Paragraph 4, Drugs in Part A of F2, after “Gemcitabine”,

insert: “Glucose”, “Morphine”,

[12]     Paragraph 4, Drugs in Part A of F2

omit the words:

and “Octreotide”, “Risperidone”

and substitute:

, “Octreotide”, “Risperidone”, “Sodium chloride” and “Sodium lactate compound”